Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0000950170-23-021890
Filing Date
2023-05-15
Accepted
2023-05-12 19:18:01
Documents
7
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 6-K sndl-6-k-2023q1.htm 6-K 26701
2 EX-99.1 sndl-ex99_1.htm EX-99.1 2597534
3 EX-99.2 sndl-ex99_2.htm EX-99.2 1274663
4 EX-99.3 sndl-ex99_3.htm EX-99.3 27989
5 EX-99.4 sndl-ex99_4.htm EX-99.4 28208
6 GRAPHIC img260723042_0.jpg GRAPHIC 4488
7 GRAPHIC img261646563_0.jpg GRAPHIC 4488
  Complete submission text file 0000950170-23-021890.txt   3968848
Mailing Address 919 11 AVENUE SW SUITE 300 CALGARY A0 T2R1P3
Business Address 919 11 AVENUE SW SUITE 300 CALGARY A0 T2R1P3 14039485227
SNDL Inc. (Filer) CIK: 0001766600 (see all company filings)

EIN.: 000000000 | State of Incorp.: A0 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-39005 | Film No.: 23917782
SIC: 2833 Medicinal Chemicals & Botanical Products